In recent years，porcine rotavirus（PoRV）has shown a high incidence trend worldwide and has surpassed traditional pathogens such as porcine epidemic diarrhea virus（PEDV）and transmissible gastroenteritis virus（TGEV）to become the dominant cause diarrhea in piglets. The virus exhibits high tissue tropism，primarily infecting the small intestinal mucosal epithelial cells of piglets from birth to weaning（1-6 weeks of age）. Clinically， infected piglets present with markedly increased defecation frequency and pass watery，light yellow or grayish?white feces，accompanied by rapid dehydration and electrolyte imbalance，ultimately leading to death from circulatory failure. Furthermore，intestinal barrier damage caused by the virus predisposes affected piglets to secondary infections by other pathogenic bacteria，with morbidity rates in piglet populations reaching as high as 100%. Currently，the prevalence of porcine rotavirus has become a key factor restricting the sustainable development of the pig farming industry. The segmental nature of the viral genome facilitates recombination with rotaviruses from other host species. In recent years，the identification of human? porcine recombinant strains and novel native variants has raised concerns regarding potential zoonotic transmission. This article systematically reviews the etiological characteristics， epidemiology and genetic variations，pathological changes and pathogenic mechanisms，diagnostic methods，and vaccine development progress associated with porcine rotavirus，with the aim of providing a comprehensive overview of current research advancements and establishing a theoretical basis for assessing the risk of cross?species transmission of this virus.